EUVIMEDEUVIMED entdecken
Fallbericht

Medication-related osteonecrosis of the jaw with severe soft tissue necrosis associated with osimertinib therapy

H Hayashi, E Aizawa, Y Sugiura, T Noguchi

International Journal of Oral and Maxillofacial Surgery · 2026-09 · 55 (9) · 1041-1045

DOI: 10.1016/j.ijom.2026.02.022 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Oral and Maxillofacial Surgery, 2026-09. Verfasst von H Hayashi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dentistry, Oral and Maxillofacial Surgery, Jichi Medical University, Yakushiji, Shimotsukeshi, Tochigi, Japan. Electronic address: hiro…. Hauptthemen laut MEDLINE: Aniline Compounds, Acrylamides, Osteonecrosis, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osimertinib, an epidermal growth factor receptor tyrosine kinase inhibitor, improves the progression-free and overall survival of patients with inoperable or recurrent non-small cell lung cancer. However, it is reportedly associated with osteonecrosis of the jaw and oral mucositis due to its ability to reduce osteoclast differentiation and inhibit angiogenesis. A 73-year-old woman had been receiving osimertinib for recurrence after lung adenocarcinoma surgery; 3 years later she presented with bone exposure and buccal mucosal necrosis. After the clinical diagnosis of medication-related osteonecrosis of the jaw with soft tissue necrosis, osimertinib was discontinued. Four months after discontinuing osimertinib, she underwent hemimandibular resection and immediate fibular graft reconstruction under general anesthesia. Eight months postoperatively, the wound had healed, and graft ossification was satisfactory. This case highlights that osimertinib may be linked to osteonecrosis of the jaw and soft tissue necrosis. When discontinuing osimertinib, close cooperation between cancer physicians and dentists is essential, given the potential for underlying disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aniline CompoundsAcrylamidesOsteonecrosisAntineoplastic AgentsProtein Kinase InhibitorsHumansFemaleIndolesAgedPyrimidinesLung NeoplasmsNecrosisNeoplasm Recurrence, LocalAdenocarcinomaCarcinoma, Non-Small-Cell Lung

Stichwörter der Autor:innen

Bisphosphonate-associated osteonecrosis of the jawEGF receptorLung neoplasmsNecrosisTyrosine kinase inhibitor

Substanzen

Aniline CompoundsIndolesAcrylamidesPyrimidinesosimertinibAntineoplastic AgentsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Dentistry, Oral and Maxillofacial Surgery, Jichi Medical University, Yakushiji, Shimotsukeshi, Tochigi, Japan. Electronic address: hirosakah@jichi.ac.jp.
  • Department of Dentistry, Oral and Maxillofacial Surgery, Jichi Medical University, Yakushiji, Shimotsukeshi, Tochigi, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Hayashi, H., Aizawa, E., Sugiura, Y., & Noguchi, T. (2026). Medication-related osteonecrosis of the jaw with severe soft tissue necrosis associated with osimertinib therapy. International Journal of Oral and Maxillofacial Surgery, 55(9), 1041-1045. https://doi.org/10.1016/j.ijom.2026.02.022

Vancouver

Hayashi H, Aizawa E, Sugiura Y, Noguchi T. Medication-related osteonecrosis of the jaw with severe soft tissue necrosis associated with osimertinib therapy. International Journal of Oral and Maxillofacial Surgery. 2026;55(9):1041-1045. doi:10.1016/j.ijom.2026.02.022

BibTeX
@article{Hayashi2026,
  author = {Hayashi, H and Aizawa, E and Sugiura, Y and Noguchi, T},
  title = {Medication-related osteonecrosis of the jaw with severe soft tissue necrosis associated with osimertinib therapy},
  journal = {International Journal of Oral and Maxillofacial Surgery},
  year = {2026},
  volume = {55},
  number = {9},
  pages = {1041--1045},
  doi = {10.1016/j.ijom.2026.02.022}
}
Kostenlos starten →